Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Antifungal Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans , and Aspergillus Species from Taiwan: Surveillance of Multicenter Antimicrobial Resistance in Taiwan Program Data from 2003
2005
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Associations Between HIV-Related Stigma, Racial Discrimination, Gender Discrimination, and Depression Among HIV-Positive African, Caribbean, and Black Women in Ontario, Canada
2013
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Effects of Tobacco Taxation and Pricing on Smoking Behavior in High Risk Populations: A Knowledge Synthesis
2011 Standout
To what extent does socioeconomic status explain differences in health between Roma and non-Roma adolescents in Slovakia?
2009 Standout
Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
2007
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Cryptococcus neoformans Meningitis at 2 Hospitals in Washington, D.C.: Adherence of Health Care Providers to Published Practice Guidelines for the Management of Cryptococcal Disease
2005
Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub‐Saharan Africa
2010
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy
2000
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Flucytosine therapeutic monitoring: 15 years experience from the UK
2007
Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era
2008
Global health burden and needs of transgender populations: a review
2016 Standout
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
2006 Standout
Primary Cutaneous Cryptococcosis: A Distinct Clinical Entity
2003
Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections
2014
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Toward more effective antifungal therapy: the prospects of combination therapy
2004
Natural products: A continuing source of novel drug leads
2013 Standout
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda
2007
DERMATOLOGIC INFECTIONS IN THE IMMUNOCOMPROMISED (Non-HIV) HOST
2001
Endobronchial Fungal Disease: An Under-Recognized Entity
2006
Reliability and Validity of French, German, Italian, Dutch, and UK English Translations of the Medical Outcomes Study HIV Health Survey
1999
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
High‐Dose Amphotericin B with Flucytosine for the Treatment of Cryptococcal Meningitis in HIV‐Infected Patients: A Randomized Trial
2008
Effect of Mode of Administration on I–PSS Scores in a Large BPH Patient Population
2001
Prevalence, Determinants of Positivity, and Clinical Utility of Cryptococcal Antigenemia in Cambodian HIV-Infected Patients
2007
Dose Response Effect of High‐Dose Fluconazole for HIV‐Associated Cryptococcal Meningitis in Southwestern Uganda
2008
Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
2010
Racism as a Determinant of Health: A Systematic Review and Meta-Analysis
2015 Standout
Fungal infections in solid organ transplantation
2007
Therapy for fungal diseases: opportunities and priorities
2010
Fluconazole encapsulation in PLGA microspheres by spray-drying
2004
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Cryptococcosis in Organ Transplant Recipients: An Overview
2002
Liposomal Amphotericin B
2009
Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis
2008
Pulmonary Cryptococcosis in Nonimmunocompromised Patients
2003
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
2008
PI3K signaling of autophagy is required for starvation tolerance and virulenceof Cryptococcus neoformans
2008 StandoutNobel
Liposomal amphotericin B: clinical experience and perspectives
2005
Current Options in Antifungal Pharmacotherapy
2008
Cryptococcosis
2006
Cerebral aspergillosis: tissue penetration is the key
2009
Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
2008
Challenges and opportunities for the implementation of virological testing in resource‐limited settings
2012
Lung cancer, a new challenge in the HIV-infected population
2005
Cryptococcus gattii:in vitrosusceptibility to the new antifungal albaconazole versus fluconazole and voriconazole
2005
Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole
2006
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
2006
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Measuring access to social capital: The validity and reliability of the Resource Generator-UK and its association with common mental disorder
2007
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Fungal Infections in Older Adults
2001
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
An investigation into nonresponse bias in a postal survey on urinary symptoms
2003
The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana
2008
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs
2006
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Cryptococcus neoformans meningoencephalitis in African children with acquired immunodeficiency syndrome
2002
The contribution of melanin to microbial pathogenesis
2003
Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole Therapy
2001
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies
2006
Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review
2005
Telephone versus In-Person Clinical and Health Status Assessment Interviews in Patients with Bipolar Disorder
1997
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
2007
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures
2009
Antifungal Agents in Children
2005
Participation Rates in Epidemiologic Studies
2007 Standout
Liposomes as nanomedical devices
2015 Standout
Advances and challenges in management of invasive mycoses
2005
The Poor Prognosis of Central Nervous System Cryptococcosis among Nonimmunosuppressed Patients: A Call for Better Disease Recognition and Evaluation of Adjuncts to Antifungal Therapy
2006
Antifungal therapy in invasive fungal infections
2010
Activity of posaconazole in the treatment of central nervous system fungal infections
2005
Mode of questionnaire administration can have serious effects on data quality
2005
Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole
2007
Immunity to fungal infections
2011 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
What is an adequate sample size? Operationalising data saturation for theory-based interview studies
2009 Standout
Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans
2007
Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study
2009
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Case 11-2008
2008
Recombinant Interferon‐γ1b as Adjunctive Therapy for AIDS‐Related Acute Cryptococcal Meningitis
2004
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome
2016
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures
2000 Standout
Transgender Health Disparities: Comparing Full Cohort and Nested Matched-Pair Study Designs in a Community Health Center
2014
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Rating evidence in treatment guidelines
2013
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Combination Treatment of Invasive Fungal Infections
2005
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B
2002
Efficacy of Amphotericin B in Combination with Flucytosine against Flucytosine-Susceptible or Flucytosine-Resistant Isolates of Cryptococcus neoformans during Disseminated Murine Cryptococcosis
2005
Common Method Bias in Marketing: Causes, Mechanisms, and Procedural Remedies
2012 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
Copper Active Sites in Biology
2014 Standout
Cutaneous Fungal Infections in the Oncology Patient
2006
Epidemiology of HIV-associated cryptococcosis in France (1985–2001)
2004
Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003
2008
Combination Antifungal Therapy
2004
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Causes of Death among Persons with AIDS in the Era of Highly Active Antiretroviral Therapy: New York City
2006
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Pharmacology of Systemic Antifungal Agents
2006
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Pulmonary fungal infections after bone marrow transplantation: the value of high-resolution computed tomography in predicting their etiology
2011
Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with Cryptococcosis
2006
Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses toCryptococcus neoformans
2001
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans , and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods
2005
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Sensitivity to Cigarette Prices Among Individuals With Alcohol, Drug, or Mental Disorders
2010
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Cryptococcus Infection in Tropical Australia
2004
Nonresponse Rates and Nonresponse Bias in Household Surveys
2006 Standout
Cryptococcosis in HIV-infected children.
2004
Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans
2006
Optimal T Cell Responses to Cryptococcus neoformans Mannoprotein Are Dependent on Recognition of Conjugated Carbohydrates by Mannose Receptors
2002
Treatment options of invasive fungal infections in adults
2006
Hidden Killers: Human Fungal Infections
2012 Standout
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
2008
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis
2005 Standout
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
2008
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.
2006
Invasive fungal infections: a review of epidemiology and management options
2006
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
2008
Works of M. S. Saag being referenced
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
2008
The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS
1997
HIV Discrimination and the Health of Women Living with HIV
2007
Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy
2011
Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002
2004
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout